These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


125 related items for PubMed ID: 38360540

  • 1. Splice Acceptor Mutation [HBB:c.93-2A > T] in a Patient with Hb S/β0-Thalassemia.
    Waye JS, Hanna M, Nakamura L, Walker L, Eng B, Nfonsam LE.
    Hemoglobin; 2024 Mar; 48(2):116-117. PubMed ID: 38360540
    [Abstract] [Full Text] [Related]

  • 2. Hb S/β-Thalassemia in the REDS-III Brazil Sickle Cell Disease Cohort: Clinical, Laboratory and Molecular Characteristics.
    Belisário AR, Carneiro-Proietti AB, Sabino EC, Araújo A, Loureiro P, Máximo C, Flor-Park MV, Rodrigues DDOW, Ozahata MC, McClure C, Mota RA, Gomes Moura IC, Custer B, Kelly S, Recipient Epidemiology and Donor Evaluation Study (REDS-III) International Component Brazil.
    Hemoglobin; 2020 Jan; 44(1):1-9. PubMed ID: 32172616
    [Abstract] [Full Text] [Related]

  • 3. Hb S (HBB: c.20A>T) and α- and β-Thalassemia Coinheritance in Iranian Patients.
    Azarkeivan A, Cohan N, Niazkar HR, Azizi A, Rad F.
    Hemoglobin; 2020 Mar; 44(2):109-112. PubMed ID: 32370567
    [Abstract] [Full Text] [Related]

  • 4. Compound Heterozygote of Hb S (HBB: c.20A>T)/Hb Westdale (HBB: c.380_396delTGCAGGCTGCCTATCAG): Report of Four Cases from Odisha State, India.
    Dehury S, Meher S, Patel S, Das K, Jana A, Bhattacharya S, Sahoo S, Sarkar B, Mohanty PK.
    Hemoglobin; 2019 Mar; 43(2):132-136. PubMed ID: 31190580
    [Abstract] [Full Text] [Related]

  • 5. Hb S/β+-thalassemia due to Hb sickle and a novel deletion of DNase I hypersensitive sites HS3 and HS4 of the β locus control region.
    Amid A, Cheong M, Eng B, Hanna M, Hohenadel BA, Nakamura LM, Walker L, Odame I, Kirby-Allen M, Waye JS.
    Haematologica; 2015 May; 100(5):e166-8. PubMed ID: 25682598
    [No Abstract] [Full Text] [Related]

  • 6. Prenatal molecular diagnosis of β-thalassemia and sickle cell anemia in the Syrian population.
    Murad H, Moassas F, Jarjour R, Mukhalalaty Y, Al-Achkar W.
    Hemoglobin; 2014 May; 38(6):390-3. PubMed ID: 25405916
    [Abstract] [Full Text] [Related]

  • 7. Profiling of 35 Cases of Hb S/Hb E (HBB: c.20A>T/HBB: c.79G>a), Disease and Association with α-Thalassemia and β-Globin Gene Cluster Haplotypes from Odisha, India.
    Dehury S, Mohanty PK, Patel S, Meher S, Das K, Purohit P, Sahoo S, Ratha J.
    Hemoglobin; 2021 Nov; 45(6):380-386. PubMed ID: 35243949
    [Abstract] [Full Text] [Related]

  • 8. Compound Heterozygosity of β-Thalassemia and the Sickle Cell Hemoglobin in Various Populations of Chhattisgarh State, India.
    Jha AN, Mishra H, Verma HK, Pandey I, Lakkakula BVKS.
    Hemoglobin; 2018 Mar; 42(2):84-90. PubMed ID: 30200838
    [Abstract] [Full Text] [Related]

  • 9. Hb Knossos (HBB: c.82G > T), β-globin CD 5 (-CT) (HBB: c.17_18delCT) and δ-globin CD 59 (-a) (HBD: c.179delA) mutations in a Syrian patient with β-thalassemia intermedia.
    Moassas F, Nweder MS, Murad H.
    BMC Pediatr; 2019 Feb 18; 19(1):61. PubMed ID: 30777047
    [Abstract] [Full Text] [Related]

  • 10. First Detection of a Splice Acceptor Site β-Thalassemia Mutation: IVS-I-130 (HBB: c.93-1G > C) in a Chinese Patient.
    He S, Zhang Q, Zheng C, Wei Y, Tang Y, Chen Q, Chen S.
    Hemoglobin; 2015 Feb 18; 39(4):290-1. PubMed ID: 26182339
    [Abstract] [Full Text] [Related]

  • 11. IVS-II-16 (G>C) (HBB: c.315+16G>C) or IVS-II-666 (C>T) (HBB: c.316-185C>T) Mutations Trigger an Hb S (HBB: c.20A>T)/β+-Thalassemia Phenotype in an Hb S Trait Patient.
    Uçucu S, Karabıyık T, Azik FM.
    Hemoglobin; 2021 Jul 18; 45(4):225-227. PubMed ID: 34396882
    [Abstract] [Full Text] [Related]

  • 12. β-Thalassemia major resulting from compound heterozygosity for HBB: c.92+2T>C [formerly known as IVS-I-2 (T>C)] and a novel β(0)-thalassemia frameshift mutation: HBB: c.209delG; p.Gly70Valfs*20.
    Kluge ML, Hoyer JD, Swanson KC, Oliveira JL.
    Hemoglobin; 2014 Jul 18; 38(4):292-4. PubMed ID: 24986053
    [Abstract] [Full Text] [Related]

  • 13. Hb Rush (HBB: c.304G>C): A Rare Variant Hemoglobin Mimicking the Hb S (HBB: c.20A>T) Variant on High Performance Liquid Chromatography.
    Mashon RS, Das R, Dhawan R, Kakkar N, Dhar T.
    Hemoglobin; 2020 Jan 18; 44(1):64-66. PubMed ID: 32124638
    [Abstract] [Full Text] [Related]

  • 14. Molecular Characterization and Hematological Aspects of Hb E-Myanmar [β26(B8)Glu→Lys and β65(E9)Lys→Asn, HBB: c.[79G>A;198G>C]): A Novel β-Thalassemic Hemoglobin Variant.
    Satthakarn S, Boonmee S, Panyasai S.
    Hemoglobin; 2020 Nov 18; 44(6):385-390. PubMed ID: 33222574
    [Abstract] [Full Text] [Related]

  • 15. THE Hb S/beta+ -thalassemia phenotype demonstrates that the IVS-I (-2) (A>C) mutation is a mild beta-thalassemia allele.
    Schmugge M, Waye JS, Basran RK, Zurbriggen K, Frischknecht H.
    Hemoglobin; 2008 Nov 18; 32(3):303-7. PubMed ID: 18473247
    [Abstract] [Full Text] [Related]

  • 16. Silent β-thalassemia mutations at -101 (C>T) and -71 (C>T) and their coinheritance with the sickle cell mutation in Bahrain.
    Al Moamen NJ, Mahdi F, Salman E, Ahmed T, Abbas R, Al Arrayed S, Sanad H, Ahmed AA.
    Hemoglobin; 2013 Nov 18; 37(4):369-77. PubMed ID: 23586372
    [Abstract] [Full Text] [Related]

  • 17. Elevated Hb A₂ Levels in a Patient with a Compound Heterozygosity for the (β⁺) -31 (A > G) and (β⁰) Codon 17 (A > T) Mutations Together with a Single α-Globin Gene.
    Panyasai S, Jaiping K, Pornprasert S.
    Hemoglobin; 2015 Nov 18; 39(4):292-5. PubMed ID: 26029792
    [Abstract] [Full Text] [Related]

  • 18. Genetic Background of β-Thalassemia in Northeast Algeria with Assessment of the Thalassemia Severity Score and Description of a new β0-Thalassemia Frameshift Mutation (HBB: c.374dup; p.Pro126Thrfs*15).
    Abdaoui W, Benouareth DE, Djenouni A, Renoux C, Grifi F, Gouri A, Athamnia F, Benalioua M, Joly P.
    Hemoglobin; 2019 Nov 18; 43(4-5):223-228. PubMed ID: 31603010
    [Abstract] [Full Text] [Related]

  • 19. Sickle cell/β0-thalassemia associated with the 1393 bp deletion can be associated with a severe phenotype.
    Daniel Y, Hill K, Inusa B, Thein SL, Howard J.
    Hemoglobin; 2011 Nov 18; 35(4):406-10. PubMed ID: 21797706
    [Abstract] [Full Text] [Related]

  • 20. Double Heterozygosity for Hb Durham-N.C. (HBB: c.344T>C) [β114(G16)Leu→Pro] and the IVS-I-110 (HBB: c.93-21G>A) Causing a Severe β-Thalassemia Phenotype.
    Cannata M, Cassarà F, Vinciguerra M, Licari P, Passarello C, Leto F, Lo Pinto C, Pitrolo L, Ganci R, Maggio A, Giambona A.
    Hemoglobin; 2019 May 18; 43(3):210-213. PubMed ID: 31456457
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 7.